Despite an incomplete understanding of the mechanism of action, ClpP agonists are currently under investigation as potential anti-cancer compounds due to their significant growth inhibitory effects on many different cancer cell lines and cancer models [35,39,40,41,42]. The gene discussed is CLPP; the disease is cancer.